
Feature|Articles|July 7, 2026
Curbing Cognitive Decline in Epilepsy: Introducing Cleveland Clinic’s New HAP-E Pilot Program
Author(s)Marco Meglio
Fact checked by: Nicole Canfora Lupo
Cleveland Clinic pilots HAP-E, guiding older adults to manage epilepsy and cognitive decline with lifestyle tools, medication support, and virtual access.
Advertisement
Advertisement
As the global population ages, epilepsy is becoming one of the most common, and most overlooked, neurological conditions of later life: People with epilepsy face nearly triple the risk of developing dementia, dementia patients face a 5- to 10-fold increased risk of developing epilepsy, and older adults now account for roughly a quarter of all first-time seizures.1 Despite the prevalence, few centers are dedicated to the care of patients facing the unique challenges that come with epilepsy in later years of life, including these difficult-to-treat coexisting conditions.
Related to this article

The professor of neurology at UT Southwestern Medical Center discussed emerging trials, proposed changes to myelitis diagnostic criteria and nomenclature, and the unmet needs raised by patients at this year’s symposium.

Allison B. Reiss, MD, associate professor of medicine at NYU Grossman Long Island School of Medicine discussed the often-overlooked early signs of early-onset Alzheimer disease.

As diabetes drugs are tested for repurposing in Alzheimer disease, the negative phase 3 EVOKE and EVOKE+ results for oral semaglutide have moved attention toward prevention and earlier, combination-based approaches.

Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with James F. Sumowski, PhD. [LISTEN TIME: 21 minutes]

In a phase 2a trial presented at CTAD 2026, neflamapimod kept plasma NfL stable in nonfluent variant primary progressive aphasia over 24 weeks.

Brian Lin, PhD, senior director of research at the Muscular Dystrophy Association (MDA), discussed the sessions he is most excited about at the 2027 MDA Clinical and Scientific Conference.
Advertisement
Advertisement


